FAIRFAX FINANCIAL HOLDINGS LTD/ CANFAIRFAX FINANCIAL HOLDINGS LTD/ CAN

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings28 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ORLAORLADelisted

ORLA MNG LTD NEW

56.8M$559.6M29.9%$3.68+160.30%
12 qtrssince 2022-Q3
Unchanged
0

OCCIDENTAL PETROLEUM CORP

6.1M$254.1M13.6%$57.16-26.30%
13 qtrssince 2022-Q2
Increased
61

CVS HEALTH CORPORATION

2.7M$187M10.0%$42.07+57.22%
3 qtrssince 2024-Q4
Unchanged
0

BLACKBERRY LTD

40.8M$186.8M10.0%$7.16-36.59%
27 qtrssince 2018-Q4
Decreased
0

KRAFT HEINZ CO/THE

4.9M$126.1M6.7%$28.13-11.65%
4 qtrssince 2024-Q3
Increased
81

CLEVELAND-CLIFFS INC

14.9M$113.2M6.1%$8.83-15.96%
3 qtrssince 2024-Q4
Unchanged
0
KWKWDelisted

KENNEDY-WILSON HOLDINGS INC

13.3M$90.5M4.8%$12.35-46.07%
27 qtrssince 2018-Q4
Unchanged
0

ATS CORPORATION

2.5M$79.1M4.2%$30.24+4.83%
4 qtrssince 2024-Q3
Unchanged
0

MOLSON COORS BEVERAGE CO - B

1.2M$58.6M3.1%$54.82-15.16%
3 qtrssince 2024-Q4
Increased
55

UNDER ARMOUR INC

6.3M$43M2.3%$7.42-7.16%
5 qtrssince 2024-Q2
Unchanged
0
VOOVOO
ETF

VANGUARD S&P 500 ETF

72,900$41.4M2.2%$562.000.00%
1 qtr
New
76
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

93,700$21.2M1.1%$83.74+171.36%
27 qtrssince 2018-Q4
Decreased
0

BANK OF NOVA SCOTIA

359,100$19.8M1.1%$38.41+40.73%
27 qtrssince 2018-Q4
Unchanged
0

GENERAL MOTORS CO

375,965$18.5M1.0%$31.03+59.36%
27 qtrssince 2018-Q4
Unchanged
0

PFIZER INC

650,900$15.8M0.8%$26.94-17.33%
19 qtrssince 2020-Q4
Unchanged
0

HELMERICH & PAYNE INC

974,105$14.8M0.8%$24.07-37.92%
27 qtrssince 2018-Q4
Increased
50

MERCK & CO. INC.

172,900$13.7M0.7%$64.92+19.63%
19 qtrssince 2020-Q4
Unchanged
0

JOHNSON & JOHNSON

73,400$11.2M0.6%$104.55+43.80%
27 qtrssince 2018-Q4
Unchanged
0

GARRETT MOTION INC

304,360$3.2M0.2%$7.77+33.81%
17 qtrssince 2021-Q2
Unchanged
0

COLLIERS INTL GROUP INC

22,000$2.8M0.2%$77.18+69.11%
23 qtrssince 2019-Q4
Unchanged
0
$1.9B
AUM
28
Positions
Q2 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
-16%Q1'24$1.2B-4%Q2'24$1.2B-7%Q3'24$1.1B+42%Q4'24$1.6B+19%Q1'25$1.8B+1%Q2'25$1.9B
Activity profile
$ moved · Q2'25
New28%Increased57%Decreased9%Exited6%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.0 years
<1Q0%1-4Q14%1-2Y11%2Y+75%

FAIRFAX FINANCIAL HOLDINGS LTD/ CAN manages $1.9B across 28 positions as of Q2 2025. Top holdings: ORLA (29.9%), OXY (13.6%), CVS (10.0%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.

Q2 2025 Summary

Added 2 new positions, exited 3, increased 5, trimmed 2. Top move: KHC (INCREASED, conviction 81). Portfolio: $1.9B across 28 positions.

Top holdings by portfolio weight

Total AUM$2B
ORLA29.90%
OXY13.58%
CVS9.99%
BB9.98%
KHC6.74%
CLF6.05%
KW4.83%
ATS4.23%
TAP3.13%
UAA2.30%
Other2.21%

Portfolio allocation by GICS sector

Sectors11
Basic Materials36.10%
Energy14.37%
Healthcare12.16%
Technology11.14%
Consumer Defensive9.91%
Real Estate4.98%
Industrials4.23%
Consumer Cyclical3.59%
Unknown2.21%
Financial Services1.24%
Other0.07%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Basic Materials, Energy, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction37
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TAPTAPMOLSON COORS BEVERAGE CO - B
Q1 2025 Q2 2026+808,000 shares+$9.7M
3Q
UAAUAAUNDER ARMOUR INC
Q4 2025 Q2 2026+39M shares+$258.3M
2Q
KHCKHCKRAFT HEINZ CO/THE
Q1 2026 Q2 2026+9.2M shares+$213.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used